With profit at an eight-year high, pharmaceutical May & Baker Nigeria Plc reported a 56 percent growth despite high operation ...

The Save the Children Immunisation Accelerator, funded by GSK, has awarded two innovation projects for finding unique solutions to help more children receive vaccinations. With an estimated 2.1 ...

Two innovative projects in Nigeria and Ethiopia have received significant funding from Save the Children through its Immunisation Accelerator, supported by GSK, to tackle the growing challenge of ...

The most recent news from Nigeria and across the world is available at The News Chronicle. The News Chronicle provides the ...

The innovations will be piloted in conjunction with vaccination programmes Save the Children runs in partnership with GSK in Ethiopia and Nigeria, focused on working together towards a world where no ...

With an estimated 2.1 million children in Nigeria and almost one million in Ethiopia1 classed as 'zero dose', having never ...

GlaxoSmithKline (GSK ... “and I think the country just has a demand to go big.” Nigeria has the largest malaria burden in the world, and may want these vaccines more than anyone.

In Nigeria, it is not only a stigma ... confusion and an inability to compare outcomes from different world regions. Professor Gilberto Fischer (GlaxoSmithKline (GSK), Brazil), Professor Jian-guo Hing ...

Malaria kills more than a thousand children every day. Measures like antimalarial medications and insecticide-treated bed nets, which stop infected mosquitoes from transmitting the disease-causing ...